Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study
Wesolowski, Robert, Stover, Daniel G., Lustberg, Maryam B., Shoben, Abigail, Zhao, Meng, Mrozek, Ewa, Layman, Rachel M., Macrae, Erin, Duan, Wenrui, Zhang, Jun, Hall, Nathan, Wright, Chadwick L., Gillespie, Susan, Berger, Michael, Chalmers, Jeffrey J., Carey, Alahdra, Balasubramanian, Priya, Miller, Brandon L., Amaya, Peter, Andreopoulou, Eleni, Sparano, Joseph, Shapiro, Charles L., Villalona‐Calero, Miguel Angel, Geyer, Susan, Chen, Alice, Grever, Michael R., Knopp, Michael V., Ramaswamy, Bhuvaneswari
Published in The oncologist (Dayton, Ohio) (01.08.2020)
Published in The oncologist (Dayton, Ohio) (01.08.2020)
Get full text
Journal Article